OSAKA - A type 2 diabetes drug approved by Japan's health ministry is being taken by young people seeking rapid weight loss, a growing trend fueled by social media promotion that has doctors warning of serious health risks associated with off-label use.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
Related coverage:
